Cargando…
MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity
BACKGROUND: The mesoderm induction early response 1, family member 3 (MIER3) gene has been recognized as potentially being associated with cancer. However, in relation to the development of non-small cell lung cancer (NSCLC), the expression pattern and the role of MIER3 are yet to be reported. The a...
Autores principales: | Zhang, Hongye, Wang, Ling, Bai, Juan, Jiao, Wenyu, Wang, Mingxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798777/ https://www.ncbi.nlm.nih.gov/pubmed/35117188 http://dx.doi.org/10.21037/tcr.2020.01.07 |
Ejemplares similares
-
Erratum to MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity
por: Zhang, Hongye, et al.
Publicado: (2020) -
The transcriptional cofactor MIER1-beta negatively regulates histone acetyltransferase activity of the CREB-binding protein
por: Blackmore, Tina M, et al.
Publicado: (2008) -
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer
por: Proto, Maria Chiara, et al.
Publicado: (2017) -
A potential histone-chaperone activity for the MIER1 histone deacetylase complex
por: Wang, Siyu, et al.
Publicado: (2023) -
AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway
por: Cai, Yanlin, et al.
Publicado: (2021)